LEOCLAN Co.,Ltd.

¥813.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:7681Healthcare
Country Japan
PE (Fwd) •••
TSR 7Y CAGR (5.96%)
Div yield 2.09%
ROE 2.22%
Medical Distribution
Beta (5Y) 0.01
PE TTM 41.86
TSR TTM (26.42%)
Mkt cap ¥4.814B
ROIC 5.21%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥796
(2.05%)
38.40%
Hold 12|10|9|7|7
1Q26
2Q26
3Q26
4Q26
Earnings per share¥
20.42
21.72
24.26
23.72
18.62%
21.54%
24.19%
15.39%
Revenue¥M
558.0
556.6
541.3
555.4
9.65%
7.37%
4.92%
3.68%
Peers (US$30.57M)
Cap (US$)
PE
99.54M
16.64x
30.68M
—
Capital
TTM
5Y
10Y
Leveragex
0.373
0.269
0.247
EBIT/Intx
0.582
1.131
1.155
Own earn%
42.45
11.85
(41.27)
Sh yield%
25.17
31.87
33.14
Owners
Insiders/Inst%
9.60
60.91
Short interest%
5.72
SBC / revenue%
1.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
23–28
$1 testx
—
Incr. ROIC%
0